These emerging medications , Semaglutide , represent a remarkable advancement in treating type 2 diabetes and possibly related conditions . These drugs are categorized as GLP-1 hormone activators , https://asiyaogjx297449.articlesblogger.com/63750534/semaglutide-a-comprehensive-dive-into-metabolic-agents